Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives
- PMID: 9550959
- PMCID: PMC28503
- DOI: 10.1136/bmj.316.7136.984
Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives
Abstract
Objective: To explore the usefulness of epidemiological data to guide clinical practice by seeking an answer to the question "What is the risk of cardiovascular disease among users of currently available, low dose, combined oral contraceptives who are aged less than 35 years, do not smoke, and do not have a medical condition known to increase the risk of vascular disease?"
Design: Review of all relevant published studies identified from the library of references held by Royal College of General Practitioners' Manchester Research Unit, checking of reference lists of identified studies, and Medline search.
Main outcome measures: Identification of methodologically sound studies able to address the specific clinical question.
Results: Our literature search identified 74 papers about the relation between current use of combined oral contraceptives and cardiovascular disease: 23 papers reporting risk of venous thromboembolism, 22 on ischaemic stroke, 13 on haemorrhagic stroke or subarachnoid haemorrhage, 13 on all stroke, and 33 on myocardial infarction. Only five papers provided information that directly addressed our clinical question; all related to the risk of venous thromboembolism. Fourteen of the discarded papers probably had the potential to answer our clinical question.
Conclusions: Much of the epidemiological data about the risk of cardiovascular disease in users of combined oral contraceptives is not useful to clinicians. Some of the discarded data could be made more useful to clinicians by reanalysis. This situation is unlikely to be unique to use of contraceptives.
PIP: The authors explored whether the available epidemiological data could quantify the risk of cardiovascular disease among non-smoking users of currently available, low-dose oral contraceptives under age 35 years, without medical conditions known to increase the risk of vascular disease. To that end, they reviewed all relevant published studies identified from the library of references held by the Royal College of General Practitioners' Manchester Research Unit, the reference lists of each paper, and conducted a computerized literature search of the MEDLINE database. 74 papers were identified on the relationship between the current use of combined oral contraceptives and cardiovascular disease. 23 papers reported the risk of venous thromboembolism, 22 reported data on ischemic stroke, 13 on hemorrhagic stroke or subarachnoid stroke, 13 on all stroke, and 33 on myocardial infarction. 5 papers provided information which directly address the clinical question and 14 discarded papers could have probably answered the clinical question. These findings demonstrate that much of the epidemiological data on the risk of cardiovascular disease in users of combined oral contraceptives is not useful to clinicians, although some of the discarded data could be made more useful to clinicians through reanalysis.
Figures
Similar articles
-
Combined oral contraceptives: risks and benefits.Br Med Bull. 1993 Jan;49(1):124-39. doi: 10.1093/oxfordjournals.bmb.a072592. Br Med Bull. 1993. PMID: 8324603 Review.
-
Epidemiology of oral contraceptives and cardiovascular disease.Ann Intern Med. 1998 Mar 15;128(6):467-77. doi: 10.7326/0003-4819-128-6-199803150-00008. Ann Intern Med. 1998. PMID: 9499331 Review.
-
Oral contraceptives and myocardial infarction: results of the MICA case-control study.BMJ. 1999 Jun 12;318(7198):1579-83. doi: 10.1136/bmj.318.7198.1579. BMJ. 1999. PMID: 10364115 Free PMC article.
-
[Arterial diseases in women using combined hormonal contraceptives].Ceska Gynekol. 2002 May;67(3):157-63. Ceska Gynekol. 2002. PMID: 12078552 Review. Czech.
-
The influence of oral contraceptives on the risk of multiple sclerosis.Br J Obstet Gynaecol. 1998 Dec;105(12):1296-9. doi: 10.1111/j.1471-0528.1998.tb10008.x. Br J Obstet Gynaecol. 1998. PMID: 9883921
Cited by
-
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.Drugs. 2000 Oct;60(4):721-869. doi: 10.2165/00003495-200060040-00003. Drugs. 2000. PMID: 11085198 Review.
-
Validity of a Novel, Clinically Relevant Measure to Differentiate Functional Power and Movement Velocity and Discriminate Fall History Among Older Adults: A Pilot Investigation.Innov Aging. 2018 Oct 24;2(3):igy028. doi: 10.1093/geroni/igy028. eCollection 2018 Sep. Innov Aging. 2018. PMID: 30480147 Free PMC article.
-
Getting evidence into practice. Needs the right resources and the right organisation.BMJ. 1998 Jul 4;317(7150):6. doi: 10.1136/bmj.317.7150.6. BMJ. 1998. PMID: 9651259 Free PMC article. No abstract available.
-
Cardiovascular events associated with different combined oral contraceptives: a review of current data.Drug Saf. 2000 May;22(5):361-71. doi: 10.2165/00002018-200022050-00004. Drug Saf. 2000. PMID: 10830253 Review.
-
Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.Cochrane Database Syst Rev. 2015 Aug 27;2015(8):CD011054. doi: 10.1002/14651858.CD011054.pub2. Cochrane Database Syst Rev. 2015. PMID: 26310586 Free PMC article. Review.
References
-
- Last JM, editor. A dictionary of epidemiology. Oxford: Oxford University Press; 1988.
-
- Early Breast Cancer Trialists’ Collaborative Group. Treatment of early breast cancer Vol 1 worldwide evidence. Oxford: Oxford University Press, 1990.
-
- Hannaford PC, Webb AMC. Evidence-guided prescribing of combined oral contraceptives: Consensus Statement. Contraception. 1996;54:125–129. - PubMed
-
- Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol. 1987;69:91–95. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources